China Shineway Pharmaceutical Group Limited
HKEx Stock Code: 02877 Chinese
Financial Reports
Annual Report 2017 2016
Annual Report
Monthly Newsflash
2010 Apr Newsflash 2010
Apr Newsflash
Financial Calendar
Merrill Lynch China Investment Summit
03-05 November 2010
  China Shineway Pharmaceutical Group Limited is the largest Chinese medicine injection and soft capsule manufacturer in the PRC. Our shares are listed on the Main Board of Hong Kong Stock Exchange. Shineway is one of the Hang Seng Composite Index constituents and is named by Forbes Magazine as Asia's Best 200 Under a Billion.

Our products are primarily categorized into three major types: injection, soft capsule and granule, targeting three market segments with high growth potential, namely the middle and old aged, anti-viral and children, and are marketed under the "SHINEWAY" brand - a China Famous Trademark.
Latest News
Notice of Board Meeting   16 Aug 2017
Announcements and Notices - Profit Warning   03 Aug 2017
Change of Company Secretary and Authorised Representative   30 Jun 2017
Product Highlight
Qingkailing Soft Capsules
Clearing away heat and toxins...
Related Links
Email Alerts
Industry Regulations
Shineway's China Website Related Website of Pharmaceutical Industry